Tumor mRNA-Transfected Dendritic Cells Stimulate the Generation of CTL That Recognize Neuroblastoma-Associated Antigens, Kill Tumor Cells: Immunotherapeutic Implications

This publication has 56 references indexed in Scilit:

• Multiple defects of the antigen-processing machinery components in human neuroblastoma: immunotherapeutic implications
  Oncogene, 2005
• Preclinical evaluation of autologous dendritic cells transfected with mRNA or loaded with apoptotic cells for immunotherapy of high-risk neuroblastoma
  Cancer Gene Therapy, 2005
• Immunogenicity of Human Neuroblastoma
  Annals of the New York Academy of Sciences, 2004
• Local and systemic effects of an allogeneic tumor cell vaccine combining transgenic human lymphotactin with interleukin-2 in patients with advanced or refractory neuroblastoma
  Blood, 2003
• Quantitation of GD2 synthase mRNA by real‐time reverse transcription‐polymerase chain reaction
  Cancer, 2002
• Lymphocyte-Mediated Cytotoxicity
  Annual Review of Immunology, 2002
• High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma
  Oncogene, 2000
• Letter to the editor
  International Journal of Cancer, 1993
• HLA‐DR typing by PCR amplification with sequence‐specific primers (PCR‐SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor‐recipient matching in cadaveric transplantation
  Tissue Antigens, 1992
• Detection of tyrosine hydroxylase mRNA and minimal neuroblastoma cells by the reverse transcription-polymerase chain reaction
  European Journal of Cancer and Clinical Oncology, 1991